期刊文献+

六例肉碱棕榈酰基转移酶2缺乏症患儿临床特征及基因变异分析

Clinical characteristics and genetic analysis of six children with carnitine palmitoyltransferase 2 deficiency
下载PDF
导出
摘要 目的:探讨肉碱棕榈酰基转移酶2(CPT2)缺乏症患儿的临床表型及基因变异特点。方法:回顾性分析6例CPT2缺乏症患儿的临床和基因检测资料,采用串联质谱法检测血酰基肉碱水平,全外显子基因测序法检测基因变异。结果:6例CPT2缺乏症患儿中男性4例、女性2例,平均确诊年龄为32个月(15 d~9岁)。其中1例无临床症状及实验室检查异常、2例迟发型、3例婴儿型。3例由新生儿筛查确诊;3例因临床表现就诊,起病时有发热、肌肉乏力伴肌酶增高。5例患儿表现为游离肉碱降低,棕榈酰基肉碱、十八碳烯酰肉碱升高。6例患儿检测到CPT2基因变异8个位点(携带双位点突变4例,携带单位点突变2例),3种为已知变异(p.R631C、p.T589M和p.D255G),5种为新报道变异(p.F352L、p.R498L、p.F434S、p.A515P、c.153-2A>G)。经PolyPhen2和SIFT软件预测,5个新报道变异中c.153-2A>G和p.F352L为疑似致病变异,p.R498L、p.F434S和p.A515P为临床意义未明变异。结论:CPT2缺乏症临床表型多样,通过新生儿血串联质谱筛查及基因检测有助于早期诊断,确诊后及时治疗大多预后良好。 Objective:To investigate the clinical characteristic and genetic variants of children with carnitine palmitoyltransferase 2(CPT2)deficiency.Methods:The clinical and genetic data of 6 children with CPT2 deficiency were retrospectively analyzed.The blood acylcarnitines and genetic variants were detected with tandem mass spectrometry and whole-exon gene sequencing,respectively.Results:There were 4 males and 2 females with a mean age of 32 months(15 d-9 years)at diagnosis.One case was asymptomatic and with normal laboratory test results,2 had delayed onset,and 3 were of infantile type.Three cases were diagnosed at neonatal screening,and 3 cases presented with clinical manifestations of fever,muscle weakness,and increased muscle enzymes.Five children presented with decreased free carnitine and elevated levels of palmitoyl and octadecenoyl carnitines.CPT2 gene variants were detected at 8 loci in 6 children(4 harboring biallelic mutations and 2 harboring single locus mutations),including 3 known variants(p.R631C,p.T589M,and p.D255G)and 5 newly reported variants(p.F352L,p.R498L,p.F434S,p.A515P,and c.153-2A>G).It was predicted by PolyPhen2 and SIFT software that c.153-2A>G and p.F352L were suspected pathogenic variants,while p.R498L,p.F434S and p.A515P were variants of unknown clinical significance.Conclusions:The clinical phenotypes of CPT2 deficiency are diverse.An early diagnosis can be facilitated by neonatal blood tandem mass spectrometry screening and genetic testing,and most patients have good prognosis after a timely diagnosis and treatment.
作者 张彦 邱文娟 张惠文 陈婷 徐烽 顾学范 韩连书 ZHANG Yan;QIU Wenjuan;ZHANG Huiwen;CHEN Ting;XU Feng;GU Xuefan;HAN Lianshu(Department of Endocrinology,Hangzhou Children’s Hospital,Hangzhou 310005,China;Department of Pediatric Endocrinology and Genetic Metabolism,Xinhua Hospital Affiliated to Shanghai Jiao Tong University School ofMedicine,Shanghai Institute for Pediatric Research,Shanghai 200092,China)
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2024年第2期207-212,共6页 Journal of Zhejiang University(Medical Sciences)
基金 上海市卫生健康委员会科研项目(202140346)。
关键词 肉碱棕榈酰基转移酶2缺乏症 临床特征 CPT2基因 串联质谱技术 游离肉碱 病例报告 Carnitine palmitoyltransferase 2 deficiency Clinical features CPT2 gene Tandem mass spectrometry Free carnitine Case report
  • 相关文献

参考文献2

二级参考文献16

  • 1顾学范,韩连书,高晓岚,杨艳玲,叶军,邱文娟.串联质谱技术在遗传性代谢病高危儿童筛查中的初步应用[J].中华儿科杂志,2004,42(6):401-404. 被引量:142
  • 2韩连书,高晓岚,叶军,邱文娟,顾学范.串联质谱技术在有机酸血症筛查中的应用研究[J].中华儿科杂志,2005,43(5):325-330. 被引量:62
  • 3Zytkovicz TH, Fitzgerald EF, Marsden D, et al. Tandem mass spectrometry analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem, 2001, 47: 1945 -1955.
  • 4Chace DH, Kales TA. A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing. Clin Biochem, 2005, 38 : 296-309.
  • 5Garg U, Dasouki M. Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspect. Clin Biochem, 2006, 39 : 315 -332.
  • 6Frazier DM, Millington DS, McCandless SE, et al. The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005. J Inherit Metab Dis, 2006, 29: 76-85.
  • 7Schulze A, Lindner M, KohlmuUer D, et al. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics, 2003,111: 1399-1406.
  • 8Yoon HR, Lee Kit, Kang S, et al. Screening of newborns and high-risk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea: a three-year report. Clin Claim Acta, 2005, 354:167-180.
  • 9Huang HP, Chu KL, Chien YH, et al. Tandem mass neonatal screening in taiwan- report firm one center. J Formos Med Assoc, 2006, 105 : 882-886.
  • 10Shigematsu Y, Hirano S, Hata I, et al. Newborn mass screening and selective screening using elctrospray tandem mass spectrometry in Japan. J Chromatogr B, 2002, 776:39-48.

共引文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部